U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Drug Development Tool (DDT) Qualification Programs
  5. Clinical Outcome Assessment (COA) Qualification Program
  6. DDT COA #000007: The Cystic Fibrosis Respiratory Symptom Diary – Chronic Respiratory Infection Symptom Score (CFRSD-CRISS)
  1. Clinical Outcome Assessment (COA) Qualification Program

DDT COA #000007: The Cystic Fibrosis Respiratory Symptom Diary – Chronic Respiratory Infection Symptom Score (CFRSD-CRISS)

Clinical Outcome Assessments (COA) Qualification Submissions
Office of Infectious Diseases (OID)
Division of Anti-Infectives (DAI)

DDT COA Number
DDT COA #000007

Instrument Name
The Cystic Fibrosis Respiratory Symptom Diary – Chronic Respiratory Infection Symptom Score (CFRSD-CRISS)

Disease/Condition
Cystic Fibrosis (CF)

Concept of Interest
CF symptom severity

Context of Use
Adolescents (≥12 years) and adults with a chronic respiratory infection in stable patients and patients with an acute exacerbation

COA Type
PRO

Qualification Stage
In legacy process*

Requestor(s)
Evidera
The Cystic Fibrosis Foundation

Contact(s)
Robin Pokrzywinski

Date Accepted into CDER’s COA Qualification Program
October 30, 2013

*Under review prior to the passage of the 21st Century Cures Act

Back to Top

Back to Top